351 related articles for article (PubMed ID: 17701332)
1. NMDA receptors in hyperammonemia and hepatic encephalopathy.
Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V
Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
3. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
[TBL] [Abstract][Full Text] [Related]
5. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo.
González-Usano A; Cauli O; Agustí A; Felipo V
J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932
[TBL] [Abstract][Full Text] [Related]
7. Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.
de Knegt RJ; Kornhuber J; Schalm SW; Rusche K; Riederer P; Tan J
Metab Brain Dis; 1993 Jun; 8(2):81-94. PubMed ID: 8355641
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
9. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure.
Rodrigo R; Erceg S; Rodriguez-Diaz J; Saez-Valero J; Piedrafita B; Suarez I; Felipo V
J Neurochem; 2007 Jul; 102(1):51-64. PubMed ID: 17286583
[TBL] [Abstract][Full Text] [Related]
10. Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain.
Erceg S; Monfort P; Hernandez-Viadel M; Llansola M; Montoliu C; Felipo V
Brain Res; 2005 Mar; 1036(1-2):115-21. PubMed ID: 15725408
[TBL] [Abstract][Full Text] [Related]
11. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
12. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
Felipo V
World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
[TBL] [Abstract][Full Text] [Related]
13. Glutamate transporter and receptor function in disorders of ammonia metabolism.
Butterworth RF
Ment Retard Dev Disabil Res Rev; 2001; 7(4):276-9. PubMed ID: 11754522
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
15. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts.
Erceg S; Monfort P; Hernández-Viadel M; Rodrigo R; Montoliu C; Felipo V
Hepatology; 2005 Feb; 41(2):299-306. PubMed ID: 15660436
[TBL] [Abstract][Full Text] [Related]
17. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
Monfort P; Muñoz MD; Felipo V
Metab Brain Dis; 2005 Dec; 20(4):265-74. PubMed ID: 16382337
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
[TBL] [Abstract][Full Text] [Related]
20. Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum.
ElMlili N; Boix J; Ahabrach H; Rodrigo R; Errami M; Felipo V
J Neurochem; 2010 Feb; 112(4):1005-14. PubMed ID: 20002515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
